Impact of glycosylated hemoglobin (HBA1C) on the extent of perfusion abnormalities and left ventricular dysfunction using gated myocardial perfusion imaging and clinical outcomes in diabetic patients

Nuclear Medicine Communications

Volumn 34, Issue 5, 2013, Pages 489-494

  Fatima, Nosheen ^a,b   Zaman, Maseeh U ^a,c   Ishaq, Muhammad ^a   Baloch, Dad J ^a   Bano, Maryam ^a   Bano, Samreen ^a   Bano, Naila ^a   Bano, Nighat ^a  

^a Karachi Institute of Heart Diseases (KIHD)   (Pakistan)

^b KIRNA Hospital   (Pakistan)

^c AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

diabetic patients; fatal myocardial infarction; gated myocardial perfusion imaging; HBA1C; nonfatal myocardial infarction

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIABETIC PATIENT; DIAGNOSTIC VALUE; DISEASE DURATION; DISEASE SEVERITY; EVENT FREE SURVIVAL; FEMALE; GAMMA CAMERA; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL PERFUSION IMAGING; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

BLOOD CIRCULATION; CARDIAC-GATED IMAGING TECHNIQUES; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; PROGNOSIS; ROC CURVE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84876416791     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32835fe2e0     Document Type: Article

References (28)

1. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Da Mey JA, Barrett EJ, et a.l. Detection of ischemia in asymptomatic diabetics in Mestigators. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: The DIAD study. Diabetes Care 2004; 27:1954-1961.
2. Third joint task force of European and other societies on cardio Mascular disease pre Mention in clinical practice. European guidelines on cardio Mascular disease pre Mention in clinical practice. Eur J Cardio Masc Pre M Rehabil 2003; 10:S1-S78.
3. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complication; report of a WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus. Gene Ma: World Health Organization; 1999.
4. Bonora E, Tuomilehto J. The pros and cons of diagnosing diabetes with A1C. Diabetes Care 2011; 34:S184-S190.
5. Jafar TH, Qadri Z, Chatur Medi N. Coronary artery disease epidemic in Pakistan More electrocardiographic e Midence of ischemia in women than in men. Heart 2008; 94:408-413.
6. Kang X, Berman DS, Lewin H. Comparati Me ability of myocardial perfusion single photon emission computed tomography to detect coronary artery disease in patients with and without diabetes mellitus. Am Heart J 1999; 137:949-957.
7. Miller T, Rajagopalan N, Hodge D, Frye R, Gibbons R. Yield of stress SPECT in asymptomatic patients with diabetes. Am Heart J 2004; 147:890-896.
8. Thomas CG, Birgit K, Panithaya C. Coronary computed tomographic angiography and exercise electrocardiography: A great match or unequal partners? Eur Heart J 2007; 28:1787-1789.
9. Wackers F.J. Diabetes in coronary artery disease; the role of stress myocardial perfusion imaging. Cle Me Clin J Med 2005; 72:21-33.
10. Salonen JT, Lakka TA, Lakka HM, Malkonen MP, E Merson SA, Kaplan G.A. Hyperinsulinemia is associated with the incidence of hypertension and dyslipidemia in middle-aged men. Diabetes 1998; 47:270-275.
11. Chipkin SR, Frid D, Alpert JS, Baker SP, Dalen JE, Aronin N. Frequency of painless myocardial ischemia during exercise tolerance testing in patients with and without diabetes mellitus. Am J Cardiol 1987; 59:61-65.
12. Rajagopalan N, Miller T, Hodge D, Frye R, Gibbons R. Identifying high risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging. J Am Coll Cardiol 2005; 45:43-49.
13. Janand-Delenne B, Sa Min B, Habib G, Bory M, Mogue P, Lassman- Mague M. Silent myocardial ischemia in patients with diabetes: Who to screen. Diabetes Care 1999; 22:1396-1400.
14. Koehli M, Monbaron D, Prior JO, Calcagni ML, Fi Maz-Arbane M, Stauffer JC, et a.l. SPECT myocardial perfusion imaging: long-term prognostic Malue in diabetic patients with and without coronary artery disease. Nuklearmedizin 2006; 45:74-81.
15. Zellweger MJ, Hachammo Mitch R, Kang X, Hayes SW, Friedman JD, Germano G, et a.l. Prognostic rele Mance of symptoms Mersus objecti Me e Midence of coronary artery disease in diabetic patients. Eur Heart J 2004; 25:543-550.
16. Goraya TY, Leibson CL, Palumbo PJ,Weston SA, Killian JM, Pfeifer EA, et a.l. Coronary atherosclerosis in diabetes mellitus. A population based study. J Am Coll Cardiol 2002; 40:946-953.
17. American Diabetes Association. Consensus de Melopment conference on the diagnosis of coronary heart disease in people with diabetes: 10-11 February 1998, Miami, Florida. Diabetes Care 1998; 21:1551-1559.
18. Emmett L, Gaal MJW, Magee M, Bass S, Ali O, Freedman SB, et a.l. Prospecti Me e Maluation of the impact of diabetes and lefT Mentricular hypertrophy on the relationship between ischemia and transient ischemic dilation of lefT Mentricle on single day adenosine Tc-99m myocardial perfusion imaging. J Nucl Cardiol 2008; 15:638-643.
19. Zaman M, Fatima N, Samad A, Ishaq M, Wali A, Rehman K, Bano J. Predicti Me and prognostic Malues of transient ischemic dilatation of lefT Mentricular ca Mity for coronary artery disease and impact of Marious managements on clinical outcome using technetium-99m sestamibi gated myocardial perfusion imaging. Ann Nucl Med 2011; 25:566-570.
20. Cakmak M, Cakmak N, Cetemen S, Tanri Merdi H, Enc Y, Teskin O, Kilic I.D. The Malue of admission glycosylated hemoglobin le Mel in patient with acute myocardial infarction. Can J Cardiol 2008; 24:375-378.
21. Mani ME, Mary J, Calton R. Impact of HbA1c on acute cardiac states. J Assoc Physicians India 2011; 59:1-3.
22. Chowdhury TA, Lasker S.S. Ele Mated glycated hemoglobin in non-diabetic patients is associated with an increased mortality in myocardial infarction. Postgrad Med J 1998; 74:480-481.
23. Turner RC, Millns H, Neil HAW, Stratton IM, Manley SE, Matthews DR, Holman R.R. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospecti Me Diabetes Study (UKPDS: 23). BMJ 1998; 316:823-828.
24. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in non diabetic subjects with an without prior myocardial infarction. N Engl J Med 1998; 339:229-234.
25. Gerstein H.C. Glycosylated hemoglobin. Finally ready for prime time as a cardio Mascular risk factor. Ann Intern Med 2004; 141:475-476.
26. Sarwar N, Aspelund T, Eiriksdottir G, Gobi R, Seshasai SRK, Forouhi N.G. Markers of dysglycemia and risk of coronary heart disease in people without diabetes; Reykja Mik prospecti Me study and systematic re Miew. PLoS Med 2010; 7:e1000278.
27. Tomo Ma GS, Nimbal M, Horwich T.B. Relation between hemoglobin A1c and outcomes in heart failure patients with and without diabetes mellitus. Am J Cardiol 2012; 12:1767-1773.
28. Guder G, Frantz S, Bauersachs J, Allolio B, Wanner C, Koller MT, et a.l. Re Merse epidemiology in systolic and nonsystolic heart failure: Cumulati Me prognostic benefit of classical cardio Mascular risk factors. Circ Heart Fail 2009; 2:563-571.